Astellas Pharma Inc. (ALPMY)
OTCMKTS
· Delayed Price · Currency is USD
9.87
-0.05 (-0.50%)
Jun 4, 2025, 3:57 PM EDT
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of $17.72 billion as of June 5, 2025. Its market cap has increased by 0.87% in one year.
Market Cap
17.72B
Enterprise Value
22.22B
Revenue
12.77B
Ranking
n/a
PE Ratio
52.30
Stock Price
$9.87
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 6.96B to 17.72B, an increase of 154.55%. That is a compound annual growth rate of 2.84%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.60B |
Veradigm | 730.27M |
Nika Pharmaceuticals | 667.06M |
Tian'an Technology Group | 614.49M |
Elite Pharmaceuticals | 570.72M |
Glass House Brands | 460.36M |
CytoDyn | 430.80M |
Northwest Biotherapeutics | 392.36M |